PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
 
Antimicrob Agents Chemother. 2009 November; 53(11): 4957–4958.
Published online 2009 August 31. doi:  10.1128/AAC.00675-09
PMCID: PMC2772332

High Prevalence of CTX-M-Type β-Lactamases among Clinical Isolates of Enterobacteriaceae in Bamako, Mali[down-pointing small open triangle]

Véronique Duval
Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière
CHU Reims
UFR Médecine Reims Champagne-Ardenne
51092 Reims, France
Ibrahim Maiga and Aminata Maiga
Laboratoire de Microbiologie
Hôpital du Point G, BP 333
Bamako, Mali

In 2004, Weil et al. reported the presence of CTX-M-15 in Salmonella enterica (10), and recently Ruppé et al. reported the carriage of CTX-M-15-producing isolates in children in a remote village in Senegal (8). However, since the report of SHV-type enzymes in Nigeria (1), no survey has been performed on extended-spectrum β-lactamase (ESBL) producers in West African hospitals (4, 7). Between May 2004 and April 2006, in Hôpital du Point G, Bamako, Mali, of 1,193 nonrepetitive isolates of Enterobacteriaceae identified by the API 20E system (bioMérieux, Marcy l'Étoile, France), 256 produced an ESBL detected by the double-disk synergy test (9) (156/747 Escherichia coli, 82/217 Klebsiella pneumoniae, 15/81 Enterobacter cloacae, 2/12 Morganella morganii, and 1/36 Proteus mirabilis isolates). Enzymes were identified for 109 E. coli and 63 K. pneumoniae isolates randomly selected every 3 months and for all E. cloacae, M. morganii, and P. mirabilis isolates. These strains were isolated from patients hospitalized in the medical (n = 127 [66.3%]) and surgical (n = 27 [14.0%]) wards and intensive care units (n = 2 [1.2%]) and emergency patients (n = 4 [2.3%]) and outpatients (n = 30 [15.7%]) and from urine (n = 142 [74.7%]), blood (n = 12 [6.3%]), pus (n = 20 [10.4%]), and other sites (n = 16 [8.3%]) (stool, catheter, and pleural and peritoneal fluid). Antimicrobial susceptibility was determined by disk diffusion according to the recommendations of the Antibiogram Committee of the French Society for Microbiology (http://www.sfm.asso.fr/) (Table (Table1).1). Isoelectric focusing evidenced only one pI corresponding to a TEM-type enzyme, pI 5.4, in 121/190 isolates. Since this pI was considered as TEM-1 in most cases, we did not screen other TEM-type ESBLs by PCR. All 190 isolates were positive for blaSHV- or blaCTX-M-related genes, as assessed by PCR using previously described specific primers (2). After direct sequencing of PCR products (2), CTX-M-15 (n = 157), CTX-M-14 (n = 17), SHV-12 (n = 17), and SHV-27 (n = 1) were identified. Two isolates produced two ESBLs, CTX-M-15 and SHV-12 or SHV-27 (Table (Table1).1). Except in three isolates of E. coli, all SHV-type enzymes were produced by E. cloacae or K. pneumoniae, confirming the role of E. coli CTX-M-15 in the increase in ESBL incidence. To determine whether the ESBL frequency was due to the spread of some predominant strains, randomly amplified polymorphic DNA (RAPD) analysis was performed (2). A great diversity of RAPD types were observed (Table (Table1),1), and no isolate was the same as E. coli O25:H4-ST 131 (3, 5). In E. cloacae species, all SHV-12-producing isolates had similar RAPD patterns, in contrast to CTX-M-15-producing isolates, which were all different.

TABLE 1.
Frequency of resistance to non-β-lactam antibiotics of ESBL-producing Enterobacteriaceae isolates

This study confirms that the worldwide diffusion of the CTX-M-15 enzyme has also reached West Africa. This was probably due to plasmid spread, since E. coli isolates, unlike SHV-12-producing E. cloacae isolates, were not genetically related (6). The spread of resistance in this area was more likely due to plasmids carrying antibiotic resistance genes than to bacterial transmission between patients. Maintenance of these plasmids was probably favored by antibiotic pressure. These findings emphasize the need for a policy of careful antibiotic use worldwide.

Acknowledgments

This work was supported by ADMIR (Association pour la Recherche en Microbiologie et Immunologie de Reims).

We are very grateful to Guillaume Arlet (Université Pierre et Marie Curie-Paris 6, France) for providing strain TN03 (E. coli O25:H4-ST 131).

Footnotes

[down-pointing small open triangle]Published ahead of print on 31 August 2009.

REFERENCES

1. Aibinu, I. E., V. C. Ohaegbulam, E. A. Adenipekun, F. T. Ogunsola, T. O. Odugbemi, and B. J. Mee. 2003. Extended-spectrum β-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria. J. Clin. Microbiol. 41:2197-2200. [PMC free article] [PubMed]
2. Brasme, L., P. Nordmann, F. Fidel, M. F. Lartigue, O. Bajolet, L. Poirel, D. Forte, V. Vernet-Garnier, J. Madoux, J. C. Reveil, C. Alba-Sauviat, I. Baudinat, P. Bineau, C. Bouquigny-Saison, C. Eloy, C. Lafaurie, D. Siméon, J. P. Verquin, F. Noël, C. Strady, and C. De Champs. 2007. Incidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study. J. Antimicrob. Chemother. 60:956-964. [PubMed]
3. Cagnacci, S., L. Gualco, E. Debbia, G. C. Schito, and A. Marchese. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612. [PMC free article] [PubMed]
4. Cantón, R., and T. M. Coque. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475. [PubMed]
5. Clermont, O., M. Lavollay, S. Vimont, C. Deschamps, C. Forestier, C. Branger, E. Denamur, and G. Arlet. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028. [PubMed]
6. Marcadé, G., C. Deschamps, A. Boyd, V. Gautier, B. Picard, C. Branger, E. Denamur, and G. Arlet. 2009. Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 63:67-71. [PubMed]
7. Rossolini, G. M., M. M. D'Andrea, and C. Mugnaioli. 2008. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin. Microbiol. Infect. 14(Suppl. 1):33-41. [PubMed]
8. Ruppé, E., P.-L. Woerther, A. Diop, A.-M. Sene, A. Da Costa, G. Arlet, A. Andremont, and B. Rouveix. 2009. Carriage of CTX-M-15-producing Escherichia coli isolates among children living in a remote village in Senegal. Antimicrob. Agents Chemother. 53:3135-3137. [PMC free article] [PubMed]
9. Sirot, J. 1996. Detection of extended-spectrum plasmid-mediated β-lactamases by disc diffusion. Clin. Microbiol. Infect. 2(Suppl. 1):35-39. [PubMed]
10. Weill, F. X., J. D. Perrier-Gros-Claude, M. Demartin, S. Coignard, and P. A. Grimont. 2004. Characterization of extended-spectrum-beta-lactamase (CTX-M-15)-producing strains of Salmonella enterica isolated in France and Senegal. FEMS Microbiol. Lett. 238:353-358. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)